Physician
Roomika T Baig MD LLC
Roomika T Baig MD LLC was paid $1.94M by Medicaid between Mar 2021 and Dec 2024, across 51 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoROOMIKA T BAIG MD LLC
FREDERICK, MD 21702
FREDERICK, MD 21702
33aNPI1316550494assigned 08/28/2020
33bProvider typePediatrics Physician
28Total paid$1.94M
24GClaims40,024
24DCodes billed51
24AFirst – last monthMar 2021 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#63 of 306
Median peer was paid$206K
This provider vs. median9.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 5,302 | $232K | |
| 2022 | 9,962 | $517K | |
| 2023 | 12,352 | $620K | |
| 2024incomplete | 12,408 | $571K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 5,159 | 4,526 | $650K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 5,711 | 5,101 | $508K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.9% | 1,445 | 1,343 | $153K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.4% | 1,381 | 1,287 | $144K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.2% | 878 | 747 | $81K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.4% | 5,528 | 5,087 | $67K |
| 92552 | 3.0% | 2,463 | 2,316 | $59K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.9% | 480 | 449 | $56K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 798 | 727 | $44K |
| 90686 | 1.8% | 1,611 | 1,494 | $35K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,040 | 914 | $17K |
| 90677 | <1% | 224 | 208 | $13K |
39 more codes
| 90698 | <1% | 552 | $12K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 313 | $10K |
| 96127 | <1% | 2,005 | $9K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 66 | $9K |
| 90656 | <1% | 379 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 495 | $6K |
| 90680 | <1% | 210 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 86 | $4K |
| 90670 | <1% | 212 | $4K | |
| 3008F | <1% | 1,044 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 174 | $4K |
| 94760 | <1% | 1,859 | $4K | |
| 99173 | <1% | 1,379 | $3K | |
| 90633 | <1% | 156 | $3K | |
| 0001A | <1% | 75 | $3K | |
| 83655 | <1% | 245 | $3K | |
| 90651 | <1% | 111 | $3K | |
| 0002A | <1% | 64 | $2K | |
| 90716 | <1% | 109 | $2K | |
| 0072A | <1% | 60 | $2K | |
| 96160 | <1% | 826 | $2K | |
| 90744 | <1% | 86 | $2K | |
| 90707 | <1% | 84 | $2K | |
| 0071A | <1% | 47 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 48 | $2K |
| 99051 | <1% | 114 | $1K | |
| 0073A | <1% | 32 | $1K | |
| 85018 | <1% | 519 | $1K | |
| 96161 | <1% | 274 | $617.83 | |
| 90688 | <1% | 17 | $395.76 | |
| 90734 | <1% | 13 | $302.64 | |
| 90715 | <1% | 13 | $302.64 | |
| 90696 | <1% | 13 | $279.36 | |
| 36416 | <1% | 499 | $58.50 | |
| 99188 | <1% | 920 | $45.00 | |
| 91300 | <1% | 67 | $0.04 | |
| 91311 | <1% | 27 | $0.01 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 14 | $0.00 |
| 99001 | 0% | 99 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAIG, ROOMIKA (MD)